
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🕒 Yesterday
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Develop and execute strategic account plans across health systems, IDNs, and treatment centers. • Lead treatment center activation, onboarding, contracting, operational readiness, and site certification. • Serve as the primary customer contact for CAR-T/cell therapy operations, logistics, and order management. • Partner cross-functionally with Sales, Marketing, Medical Affairs, Market Access, Patient Services, Supply Chain, Manufacturing, Quality, Finance, Legal, and Commercial Operations to resolve issues and deliver key performance indicators. • Support reimbursement strategies, and contracting initiatives. • Drive expansion initiatives including satellite apheresis, outpatient treatment models, and multi-site frameworks. • Analyze and monitor account performance, identify operational gaps, and implement continuous improvements. • Represent customer insights, site performance and launch readiness in senior level meetings. • Build executive relationships and lead strategic business reviews.
• Bachelor's degree required; advanced degree preferred. • 8+ years of biotechnology, pharmaceutical, cell therapy experience and proven site onboarding success. • Additional commercial experience with specialty biologics and neurology products a plus. • Experience managing health systems, IDNs, or treatment center accounts. • Knowledge of cell therapy operations, reimbursement, contracting, and GPOs. • Experience working cross-functionally within commercial and medical organizations. • Strong communication, analytical, negotiation, and executive relationship management skills.
• Bonus • Benefits • Participation in the Company's stock plan
Apply Now🕒 Yesterday
Sr Director IT Business Enablement responsible for technology roadmaps and strategic alignment for Cytiva Manufacturing & Quality. Leading initiatives for operational excellence and innovation throughout enterprise IT.
🕒 Yesterday
Senior Director Market Access leading payer engagement and market access strategies for diagnostics. Collaborating with medical and clinical teams to enhance reimbursement and reduce barriers in care.
🇺🇸 United States – Remote
💵 $180k - $210k / year
💰 Post-IPO Debt on 2019-06
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
🕒 Yesterday
Senior Director leading national and regional market access strategies at Labcorp. Collaborating across teams to secure payer engagement and reimbursement within Women’s Health & Reproductive Genetics.
🇺🇸 United States – Remote
💵 $180k - $210k / year
💰 Post-IPO Debt on 2019-06
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
🕒 Yesterday
Lead Director for Healthcare Quality Management overseeing quality strategies for Louisiana Medicaid populations. Responsible for execution of quality management initiatives and regulatory compliance at Aetna Better Health of Louisiana.
🕒 Yesterday
Senior Director guiding platform delivery and operations for Epic applications in healthcare. Collaborating with stakeholders to enhance clinical outcomes and operational efficiency.